Cytokine pharmasciences
WebFeb 25, 2008 · Cytokine PharmaSciences is a biopharmaceutical company located in King of Prussia (near Philadelphia), Pennsylvania. The company developed and manufactures Cervidil®/Propess®, used in the... WebFeb 25, 2008 · As Cytokine PharmaSciences continues to progress its pipeline of products in women's health, inflammation and cancer, we will look for key strategic alliances, such as this licensing agreement with Marillion, to maximize the …
Cytokine pharmasciences
Did you know?
In a preclinical study in rats, semapimod was found to suppress cytokine-storm induction by the anticancer cytokine interleukin-2 (IL-2) without decreasing its anticancer properties, allow larger doses of IL-2 to be administered. A subsequent phase I trial in humans failed to show an increase in the tolerated dose of IL-2, although indications of pharmacological activity as an inhibitor of tumor necrosis factor production were observed. WebApr 25, 2002 · Cytokine Pharmasciences, Inc. Citation: 2002 Del. Ch. LEXIS 48. Country: US. State or Federal: State Court. State/Jurisdiction: Delaware. Court: Court of Chancery. Experts: Jeffrey B. Davis (for Gray) J. Mark Penny (for Cytokine) Merrill Lynch (for Cytokine) Judges: Lamb. Summary. The issue in this case was the fair value of the …
WebHe joined the company in April 2024 as the Vice President, Finance. Michael has more than 15 years of experience in the pharmaceutical industry. Michael began his career in the pharmaceutical industry with Cytokine PharmaSciences (“CPSI”) focusing on … WebOct 29, 2007 · Cytokine PharmaSciences is a biopharmaceutical company located in …
WebOct 9, 2024 · Semapimod ® (cytokine, pharmasciences) Semapimod ® is a synthetic guanylhydrazone that inhibits 1) signal transduction pathways by preventing phosphorylation of p38 MAP kinase and JNK; 2) production of the proinflammatory cytokines TNF-alpha, IL-1, IL-6. MIP-1 alpha, MIP-1 beta; and 3) production of nitric oxide. WebBefore becoming CEO at Veltion Therapeutics, Dr. Sielecki worked as Vice President, …
WebCytokine PharmaSciences, Inc. is a specialty pharmaceutical company engaged in developing anti-inflammatory and autoimmune therapeutics. The Company is headquartered in King of Prussia (near Philadelphia), Pennsylvania. A wholly owned subsidiary, Controlled Therapeutics (Scotland) Limited (CT), is located in East Kilbride (near Glasgow). ...
WebNov 20, 2001 · Cytokine Pharmasciences, Inc., C.A. No. 17451, see flags on bad law, … simple as abcWebCYTOKINE PHARMASCIENCES, INC. PENNSYLVANIA FOREIGN BUSINESS CORPORATION: WRITE REVIEW: Address: 4 Tower Bridge 200 Barr Harber Dr Ste 400 West Conshohocken Montgomery, PA 19428-2978: Registered Agent: Filing Date: August 04, 1999: File Number: 2891039: Contact Us About The Company Profile For Cytokine … ravenwood fireWebCytokine PharmaSciences's oral semapimod, a synthetic anti-cytokine compound, has … ravenwood farm foundationWebCytokine PharmaSciences, Inc. is a specialty pharmaceutical company engaged in developing anti-inflammatory and autoimmune therapeutics. The Company is headquartered in King of Prussia (near Philadelphia), Pennsylvania. A wholly owned subsidiary, Controlled Therapeutics (Scotland) Limited (CTS), is located in East Kilbride (near Glasgow). simple as 1-2-3WebMay 7, 2009 · Cytokine PharmaSciences Presents Non-Clinical Data From Its Smooth Muscle Contractility Program at the American Society of Hypertension 24th Annual Scientific Meeting and Exposition - read this article along with other careers information, tips and advice on BioSpace ravenwood farm labradorsWebCytokine PharmaSciences's oral semapimod, a synthetic anti-cytokine compound, has been found to have potential in the treatment of inflammatory and autoimmune diseases including rheumatoid arthritis, Crohn's and psoriasis. The compound has previously been tested in clinical trials only as an intravenous infusion and the newly developed oral ... simple arts with explanationWebAbstract: Methods of use and pharmaceutical compositions for a genus of low molecular weight compounds comprising optionally substituted isoxazoline ring systems that act as inhibitors of MIF (macrophage migration inhibitory factor) are disclosed. Specifically, the compounds are useful for treating a variety of diseases involving inflammatory activity or … simple arts to draw